Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
CMS to Accept Electronic Payments for Conditional Payments
Keep current with new legislation and its potential effect on your organization.
StateWatch: Spring 2019
Kaiser Health News reported that doctors in a growing number of states are now required to offer a prescription for overdose antidote naloxone at the same time opioids are prescribed under certain circumstances, a development that could add to the growth in naloxone prescriptions in workers’ comp.
The New Standard for Proper and Safe Repairs
When components involved in repairs of vehicles are connected to each other, the consumer is more likely to be protected from any oversight in the repair process that could compromise safety.
Top Six Benefits IoT Offers the Automotive Claims Industry
Just one poor claims experience will lead more than 30 percent of customers to switch carriers within a year of the incident. How can insurers improve satisfaction during the claims process, make customers’ lives easier and reduce churn?
3 Takeaways from WCRI
WCRI’s recent annual conference delivered valuable research and insight on the current (and future) state of the industry.
Quarterly Drug Update: Evaluating Combination Medications
Pricing for prescription drugs is a topic of much discussion. Combination drugs are often under scrutiny as a common practice for manufacturers to create new brand medications. While these combination drugs are effective, they may be more expensive and no more effective than their separate generic components that typically come at a significantly lower Average Wholesale Price (AWP).